Navigation Links
TPI Business and Development Profile Updated on OneMedDatabase

CHENGDU, China, April 4, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics and other pharmaceuticals has updated its corporate business & development information on OneMedDatabase, a division of OneMedPlace, a New York-based healthcare research and business & development firm.

The profile is to serve as a portal for TPI in the development of partnership with U.S. as well as international pharmaceutical companies for the further growth expansion via TPI's in-depth coverage of pharmaceutical sales network in China and TPI's upcoming macrolide antibiotic API business.

The updated profile of TPI along with an interview with the management can be found via the following link:

About OneMedPlace

OneMedPlace (OMP), based in New York, is a healthcare research company that manages a business development platform to help emerging healthcare and life sciences companies maximize their potentials. OMP provides companies and investors with efficient access to information about potential opportunities around the world through an integrated set of tools including:

OneMedDatabase: Over 8,000 companies and resources.

OneMedForum: a biannual business development and investment conferences in San Francisco (January) and New York City (June).

OneMedTV: Documentaries on promising companies and technologies and important healthcare events.

Sentinel: weekly e-newsletter tracking the major healthcare industrial trends.

For more information regarding OneMedPlace, please visit:

About TPI

Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics and other pharmaceuticals. TPI currently manufactures a comprehensive portfolio of 56 products, 23 of which are listed in the highly selective national medicine reimbursement list, 7 are included in the essential drug list of China. TPI currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. TPI has an extensive nationwide distribution network with a sales force of 730 sales representatives out of totaled 1,365 employees.

For more information about TPI, please visit:

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact:

James Jiayuan Tong M.D. Ph.D.
Chief Financial Officer, Chief Business & Development Officer
Tianyin Pharmaceutical Co., Inc.

Tel:  +86-28-8551-6696 (Chengdu, China)
       +86-134-3655-0011 (China)
       +1-949-350-6999 (U.S.)


23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
Chengdu, 610041

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kronos Announces First Quarter Business Update and Financial Results
2. Growth Achieved in Spherixs Health Sciences Consulting Business
3. ImaRx Therapeutics Transitions Business Strategy
4. Argonauta Communications Certified as Women-Owned Business by the Womens Business Enterprise National Council (WBENC)
5. New Pharma Business Model Increases Pressure on Staff Communicating Trial Data
6. Small Business Innovation Research Program Awards Grant to Biomoda
7. American Dairy Provides Business Update
8. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
9. Pharmos Issues Business Update on Dextofisopam Trial and Financing
10. One Call Now Offers Notification Service at NO CHARGE for Governments, Schools, Businesses, Religious Organizations and Others in Response to Swine Flu Outbreak
11. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Post Your Comments:
(Date:11/30/2015)... November 30, 2015 --> ... "Dental Lasers Market by Product (Soft Tissue, All Tissue, Dental ... (Hospitals, Clinics), and Geography - Global Forecast to 2020", published ... 2020, at a CAGR of 5.2% during the forecast period ... data Tables and 62 Figures spread through 167 P ...
(Date:11/30/2015)... 2015  PTS Diagnostics, the U.S.-based manufacturer of point-of-care ... A1CNow ® systems, and PTS Detect™ cotinine systems, ... that will propel the company into the mHealth market. ... Europe . The technology is a system that ... smartphones and tablets, and uses test strip technology already ...
(Date:11/30/2015)... Nov. 30, 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... the development of oral drug delivery systems, announced today ... at up to $50,000,000 with Hefei Tianhui Incubator of Technologies Co., Ltd. ... capsule, ORMD-0801, in China , ... . The agreements were signed at the Israel ...
Breaking Medicine Technology:
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... two new additions to its industry-leading suite of automated breast density assessment ... North America (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). ...
(Date:11/30/2015)... ... 2015 , ... Holcomb – Kreithen Plastic Surgery and ... in Florida, is proud to announce that Dr. Joshua Kreithen, one of its ... a Johnson & Johnson Company. , Ethicon is a global medical device company ...
(Date:11/30/2015)... ... ... The successful filing of an Investigational New Drug application (IND) is a ... key industry segment, Regis Technologies has decided to sponsor and participate in an XTalks-hosted ... , Federal law does not allow new drugs to cross state lines until it ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
(Date:11/30/2015)... ... 2015 , ... GKhair & Tibolli team members and artists were excited and ... November 8th and 9th at the Puerto Rico Convention Center, San Juan Puerto Rico. ... top of the line fashion journalists. The San Juan Beauty Show carries immense credibility ...
Breaking Medicine News(10 mins):